started · updated
UKC Tuzla reports shortage of critical cancer medications
The University Clinical Center (UKC) Tuzla has released a list of five essential medications that have not been delivered by the Health Insurance Fund of the Federation of Bosnia and Herzegovina as of October 30, 2026.
The missing drugs include Idarubicin, Mitoxantron, Pemetrexed, Daunorubicin, and Everolimus. These medications are used to treat various severe conditions, including certain types of leukemia and lung cancer.
UKC Tuzla has not specified when the supplies will arrive, the reasons for the delay, or the exact number of patients currently awaiting these specific therapies.
Entities
Health Insurance Fund of the Federation of Bosnia and Herzegovina · Tuzla · University Clinical Center Tuzla